Candriam SCA’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.99M | Sell |
|
|||||
|
2025
Q1 | $7M | Sell |
|
|||||
|
2024
Q4 | $12M | Sell |
|
|||||
|
2024
Q3 | $23.9M | Sell |
|
|||||
|
2024
Q2 | $24.3M | Buy |
|
|||||
|
2024
Q1 | $13.1M | Sell |
|
|||||
|
2023
Q4 | $9.48M | Sell |
|
|||||
|
2023
Q3 | $7.61M | Sell |
|
|||||
|
2023
Q2 | $10.2M | Buy |
|
|||||
|
2023
Q1 | $7.36M | Buy |
|
|||||
|
2022
Q4 | $9.34M | Buy |
|
|||||
|
2022
Q3 | $10.8M | Sell |
|
|||||
|
2022
Q2 | $10.6M | Buy |
|
|||||
|
2022
Q1 | $10.7M | Sell |
|
|||||
|
2021
Q4 | $23M | Buy |
|
|||||
|
2021
Q3 | $16.6M | Buy |
|
|||||
|
2021
Q2 | $13.5M | Buy |
|
|||||
|
2021
Q1 | $0 | Buy |
|